€65.95
COA verified
Certificate of Analysis available
≥99% purity (HPLC)
COA-verified standard
Fast dispatch
Orders ship within 24 hours
Peptide
Retatrutide (GLP-3)
Purity ≥99% (HPLC). 5mg lyophilisate. For research purposes only.
Package
Dosage
Order before 14:00
dispatch in 48 hours
Processed
within 48 hours
Arriving
3–5 business days
Research Library — app.uptide.eu
Mechanisms, studies, pathways & COA documentation
- Form: White lyophilized powder
- Purity: ≥99.3% (HPLC-verified)
- MW: ~4759 g/mol
- Storage: Store at -20°C
- Shelf life: 2 years
Pharmaceutical-grade research peptide, lyophilized for stability. Each batch is independently tested and COA-verified with ≥99% purity by HPLC analysis. Intended exclusively for research purposes.
Retatrutide is studied as an experimental triple hormone receptor agonist targeting GLP-1, GIP and glucagon receptors simultaneously. Researchers examine obesity, body weight, glucose homeostasis, energy expenditure, lipids, liver fat and broader cardiometabolic markers. Phase 2 literature reports substantial weight reduction in adults with obesity. The scientific interest centres on whether combined incretin and glucagon receptor signalling can produce greater metabolic effects than single or dual agonists. This compound remains in clinical development.
For laboratory research use only. This information describes areas of scientific investigation and does not constitute medical advice, dosing guidance or therapeutic claims.
For research purposes only. All Uptide products are intended exclusively for research and analytical purposes by qualified professionals. Not for human consumption, diagnostic or therapeutic applications.